Director Farah Champsi sold $10.2M of Kite Pharma, Inc.

Sold$10,244,036

$82.67Price

123,913Shares

−55%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Apr 24. Filed Wed, Apr 26, 1:38 PM ET, during the session. Not investment advice.